Addex Therapeutics ADXN
NASDAQ ADXN
$3.07 +0.09 (+3.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

Addex Therapeutics (ADXN) Return on Sales [ROS] (2019 - 2026)

Updated

Addex Therapeutics (ADXN) recorded Return on Sales [ROS] of -314218.95% in Q4 2025, down 131526.64 percentage points from -182692.31% a year earlier and down 311876.82 percentage points from the prior quarter.

Analysis

Addex Therapeutics (ADXN) Return on Sales [ROS] (2019 - 2026) Analysis & Trends

For FY2025, Addex Therapeutics reported Return on Sales [ROS] of -9390.76%, down 8708.94 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of -9051.87 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -681.82% in FY2024 (-542.76 pp), -139.06% in FY2023 (+601.99 pp), -741.04% in FY2022 (-209.35 pp) and -531.70% in FY2021 (-192.81 pp).
  • The Q4 2025 figure is the lowest quarterly Return on Sales [ROS] in data going back to Q1 2019.
  • On a year-over-year basis, Return on Sales [ROS] has declined for three consecutive quarters, with an average year-over-year change of -45415.16 percentage points over the last seven quarters.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 10893.79 percentage points in Q3 2021, against a drop of 181230.60 percentage points in Q4 2024 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Addex Therapeutics 2.75 Mn 2.75 Mn - -8,739.47%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,739.47%
Dec 31, 2025 -314,218.95%
Sep 30, 2025 -2,342.13%
Jun 30, 2025 -2,834.12%
Dec 31, 2024 -182,692.31%
Sep 30, 2024 -1,155.71%
Jun 30, 2024 -780.13%
Mar 31, 2024 -337.50%
Dec 31, 2023 -1,461.70%
Sep 30, 2023 -228.61%
Jun 30, 2023 -62.80%
Mar 31, 2023 -73.47%
Dec 31, 2022 -3,463.70%
Sep 30, 2022 -1,017.78%
Jun 30, 2022 -3,868.04%
Mar 31, 2022 -2,429.04%
Dec 31, 2021 -3,901.00%
Sep 30, 2021 -524.31%
Jun 30, 2021 -454.03%
Mar 31, 2021 -372.89%
API Access

Addex Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ADXN&period=max&api_key=YOUR_API_KEY